Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism-Reference-Cited by-同舟云学术

Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism

Published:2015-11-27 Issue:3 Volume:7 Page:2765-2779
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rotin Lianne E.¹²,Gronda Marcela¹,MacLean Neil¹,Hurren Rose¹,Wang XiaoMing¹,Lin Feng-Hsu¹,Wrana Jeff³,Datti Alessandro³⁴,Barber Dwayne L.¹,Minden Mark D.¹²,Slassi Malik⁵,Schimmer Aaron D.¹²

Affiliation:

1. Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada

2. Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada

3. Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada

4. Department of Agricultural, Food, and Environmental Sciences, University of Perugia, Perugia, Italy

5. Fluorinov Pharma Inc., Toronto, Ontario, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphatase-degradable nanoparticles providing sustained drug release;International Journal of Pharmaceutics;2024-04

2. The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells;Genes to Cells;2023-11-14

3. Ethacridine Regulation of JAK/STAT/ERK Signaling Pathway in Colon Cancer Cells SW620: In vitro Approach;Pharmacognosy Magazine;2023-02-06

4. A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling;International Journal of Molecular Sciences;2022-03-22

5. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles;PLOS Pathogens;2021-09-03